Farkhad Manapov

Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy

Real-world insights into moderately hypofractionated thoracic radiotherapy in elderly and multimorbid patients with stage II/III NSCLC: a retrospective study

Empiric stereotactic body radiotherapy for presumed early-stage lung cancer

The role of online MR-guided multi-fraction stereotactic ablative radiotherapy in lung tumours

Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study

Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors

Timing of stereotactic radiosurgery within the first-line systemic treatment in non-small cell lung cancer brain metastases: a retrospective single-center cohort study

1266P Interim analysis from the multicenter ROSE study: Radiation during osimertinib treatment safety and efficacy cohort

Simultaneous object detection and segmentation for patient‐specific markerless lung tumor tracking in simulated radiographs with deep learning

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis

Radiation-Induced Lung Injury: Prevention, Diagnostics and Therapy in the Era of the COVID-19 Pandemic

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC—current state and future directions

Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients

Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART

Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition

Forging a Path for Metformin Use in Inoperable Locally Advanced Non–Small Cell Lung Cancer

Combination of pembrolizumab with radiotherapy can change treatment paradigm in metastatic “non‐driver” non‐small‐cell lung cancer: Assembling a path

Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer

Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver Alterations

Role of radiotherapy in the management of brain metastases of NSCLC – Decision criteria in clinical routine

External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy

In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Concurrent radiotherapy and nivolumab in metachronous metastatic primary adenosquamous-cell carcinoma of the prostate

Simultaneous bilateral stereotactic body radiation therapy of two inoperable centrally located pulmonary lesions in a patient with metastatic mesenchymal chondrosarcoma